Understanding & Conquering Depression | Huberman Lab Essentials

In this Huberman Lab Essentials episode, Andrew Huberman explains what major depression is, its symptoms, and the underlying biology. He covers the roles of norepinephrine, dopamine, and serotonin, how antidepressants like tricyclics, MAO inhibitors, and SSRIs work, and how hormones, stress, genetics, and inflammation contribute to depression. He then reviews behavioral and supplement-based tools, including cold exposure, exercise, EPA omega-3s, and creatine, plus emerging clinical treatments like ketamine, psilocybin, and the ketogenic diet.

• Major depression impacts roughly 5% of the population and is the number four cause of disability.
  00:00:00
• A 9:00 PM peak in cortisol is described as a physiological signature of depressive-like states.
  00:05:21
• Huberman frames much of major depression as driven by excessive, unchecked inflammation.
  00:18:47
• He says he was surprised to learn creatine can help treat mood disorders; a 2012 American Journal of Psychiatry trial found it augmented SSRI response in women.
  00:24:37
• A 2021 JAMA Psychiatry trial found 50 to 70% of subjects got significant relief from psilocybin-assisted therapy.
  00:28:48
• The ketogenic diet shows decent evidence for helping treatment-refractory depression by raising GABA activity.
  00:31:33

• Anti-self confabulation: depressed people generate self-deprecating stories about themselves that don't match reality.
  00:01:05
• Early-morning waking (3-5 AM) with inability to fall back asleep is a hallmark vegetative symptom of depression.
  00:03:44
• SSRIs raise serotonin efficacy almost immediately, yet symptom relief usually takes about two weeks to appear.
  00:11:16
• About a third of people who take SSRIs derive no benefit from them.
  00:10:13
• If one identical twin has major depression, the other has about a 50% probability; the closer the relation, the higher the risk.
  00:15:34
• About 1,000 mg of EPA per day appears to be the threshold for benefit, and it can lower the effective dose of SSRIs.
  00:20:54
• Inflammation diverts tryptophan away from serotonin into kynurenine and the neurotoxin quinolinic acid, which is pro-depressive.
  00:21:27
• Aerobic and resistance exercise shuttle kynurenine into muscle, protecting against this pro-depression pathway.
  00:22:33

Books, products and media the guest or host genuinely endorsed here — with the buy link.

Affiliate link — we may earn a commission at no extra cost to you.